Genomics News and Research RSS Feed - Genomics News and Research

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.
ASHG and Mayo Clinic collaborate to facilitate genetic and genomic education

ASHG and Mayo Clinic collaborate to facilitate genetic and genomic education

The American Society of Human Genetics and Mayo Clinic Center for Individualized Medicine announced today a formal collaboration under which the two organizations will facilitate the use of genomics in medicine through the education of health professionals. [More]
MSU experts pioneer pathways to new treatment options for pneumonia

MSU experts pioneer pathways to new treatment options for pneumonia

Streptococcus pneumoniae likely is not a term immediately recognizable by most individuals, even if they have had unpleasant run-ins with the common bacterium. However, experts at Mississippi State University are pioneering pathways to new treatment options. [More]
Duke researchers discover blood markers linked to drug-resistant tumor cells

Duke researchers discover blood markers linked to drug-resistant tumor cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies. [More]
Contaminated poultry may be source of human exposure to MRSA, research shows

Contaminated poultry may be source of human exposure to MRSA, research shows

A new study offers compelling evidence that a novel form of the dangerous superbug Methicillin-Resistant Staphylococcus aureus (MRSA) can spread to humans through consumption or handling of contaminated poultry. [More]
UCSF researchers receive funding from Susan G. Komen to support breast cancer research

UCSF researchers receive funding from Susan G. Komen to support breast cancer research

Three UCSF researchers have been awarded $680,000 in grants from Susan G. Komen to support projects in breast cancer research. [More]
Sanford wins $11.7 million NIH grant to translate laboratory cancer research into clinical trials

Sanford wins $11.7 million NIH grant to translate laboratory cancer research into clinical trials

The Cancer Biology Research Center at Sanford Research is the recipient of a five-year, nearly $11.7 million grant from the National Institutes of Health to translate laboratory research into clinical trials for head and neck and pediatric cancers. [More]
Researchers underscore importance of immune-based prevention to conquer cancer

Researchers underscore importance of immune-based prevention to conquer cancer

In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden. [More]
Researchers identify mutant traits in mouse for many human disease genes

Researchers identify mutant traits in mouse for many human disease genes

About one-third of all genes in the mammalian genome are essential for life. An international, multi-institutional research collaboration identified, for the first time, mutant traits in the mouse for 52 human disease genes, which significantly contributes to the understanding of the genetic bases for some human diseases, including cardiovascular defects, spina bifida, and metabolic disorders, among many others. The study was published this week in Nature. [More]
Researchers identify and treat new variant of antibiotic-resistant E. coli

Researchers identify and treat new variant of antibiotic-resistant E. coli

Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body's own immune system by inhibiting white blood cells that ordinarily kill and remove bacteria. [More]
BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system. [More]
Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

Individual cells within a tumor are not all the same. This may sound like a modern medical truism, but it wasn't very long ago that oncologists assumed that taking a single biopsy from a patient's tumor would be an accurate reflection of the physiological and genetic make-up of the entire mass. [More]
Scientists discover potential new genetic causes for intellectual disability

Scientists discover potential new genetic causes for intellectual disability

An international group of researchers has for the first time identified a set of 30 inherited recessive genes that play a role in intellectual disability (ID), a neurodevelopmental disorder that, according to the Centers for Disease Control, affects as many as 213 million people around the world. [More]
Tgen-NAU researchers produce anthrax genome sequence from victims of 1979 outbreak

Tgen-NAU researchers produce anthrax genome sequence from victims of 1979 outbreak

A new study by the Translational Genomics Research Institute and Northern Arizona University used deep DNA sequencing methods to generate the anthrax genome sequence from the victims of the 1979 anthrax outbreak in Sverdlovsk, Russia, when it was part of the USSR. [More]
Interactions between rare and common genetic variants may contribute to craniosynostosis

Interactions between rare and common genetic variants may contribute to craniosynostosis

During the first year of life, the human brain doubles in size, and continues growing through adolescence. [More]
New molecular mechanism may explain pain relieving drug’s diverse benefits

New molecular mechanism may explain pain relieving drug’s diverse benefits

Aspirin's ability to reduce the risk of both cardiovascular disease and colon cancer has been a welcome, yet puzzling, attribute of the pain reliever that has been a mainstay in medicine cabinets for more than 100 years. [More]
New computer program can predict underlying genomics of ER+ breast cancer

New computer program can predict underlying genomics of ER+ breast cancer

The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and which require chemotherapy, researchers at Case Western Reserve University have found. [More]
Schizophrenia drug slows pancreatic tumor growth in mice

Schizophrenia drug slows pancreatic tumor growth in mice

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center. [More]
Advances in human genotyping arrays: an interview with Rob Brainin

Advances in human genotyping arrays: an interview with Rob Brainin

Illumina sees a widespread demand for genotyping products and a continued relevance of arrays in human disease and translational research. [More]
Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

CUBRIC is one of the top neuroimaging research centres in the UK and has grown rapidly since it opened in 2006. CUBRIC is expected to become an international hub for neuroimaging, unique in Europe. [More]
New study details design and validation of accurate screening test for detecting deadly HAIs

New study details design and validation of accurate screening test for detecting deadly HAIs

A new study by the Translational Genomics Research Institute details the design and validation of a low-cost, rapid and highly accurate screening tool -- known as KlebSeq -- for potentially deadly healthcare-acquired infections (HAIs), such as Klebsiella pneumoniae. [More]
Advertisement
Advertisement